RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SMITH J
Collezione AOU Città della Salute di Torino

Items : 8

Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium. in European urology focus / Eur Urol Focus. 2024 May;10(3):461-468. doi: 10.1016/j.euf.2023.08.007. Epub 2023 Sep 12.

2024
AOU Città della Salute di Torino

Shariat SF; Tilki D; Karnes RJ; Gill I; Cathcart P; Sanchez-Salas R; Rodriguez-Sanchez L; Joniau S; Smith JA; Cacciamani G; Ahmed M; Abreu A; Conte F; Benfant N; Rajwa P; Calleris G; Marra G; Touijer K; Gontero P;

Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort. in European urology focus / Eur Urol Focus. 2023 Jul;9(4):645-649. doi: 10.1016/j.euf.2023.01.006. Epub 2023 Jan 20.

2023
AOU Città della Salute di Torino

Karnes RJ; Cathcart P; Gill I; Kretschmer A; Sanchez-Salas R; Joniau S; Persad R; Van Der Poel H; Massari E; Oderda M; Rouprêt M; Smith JA; Albisinni S; Veerman H; Raskin Y; Tourinho-Barbosa R; Westhofen T; Ribeiro L; Ghoreifi A; Cacciamani G; Ahmed M; Abreu A; Benfant N; Rajwa P; Marra G; Calleris G; Tilki D; Shariat SF; Touijer K; et alii...

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. in Leukemia / Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13.

2022
AOU Alessandria
AOU Città della Salute di Torino

Deckert M; Ponzoni M; Pennese E; Cabras G; Thurner L; Smith J; Rummel M; Hertenstein B; Schmoll HJ; Krause SW; Zanni M; Pisani F; Orsucci L; Tucci A; Panse J; Stilgenbauer S; Hess G; Keller U; Balzarotti M; Pukrop T; Gørløv JS; Linton KM; Johnson PW; Hemmaway C; Roth A; Krampera M; Ilariucci F; Fabbri A; Binder M; et alii...

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. in Blood / Blood. 2022 Apr 21;139(16):2499-2511. doi: 10.1182/blood.2021014506.

2022
AOU Città della Salute di Torino

Wilson MR; Eyre TA; Kirkwood AA; Wong Doo N; Soussain C; Choquet S; Martinez-Calle N; Preston G; Ahearne M; Schorb E; Moles-Moreau MP; Ku M; Rusconi C; Khwaja J; Narkhede M; Lewis KL; Calimeri T; Durot E; Renaud L; Øvlisen AK; McIlroy G; Ebsworth TJ; Elliot J; Santarsieri A; Ricard L; Shah N; Liu Q; Zayac AS; Vassallo F; et alii...

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study. in Urologic oncology / Urol Oncol. 2021 May;39(5):296.e21-296.e29. doi: 10.1016/j.urolonc.2020.11.002. Epub 2021 Jan 10.

2021
AOU Città della Salute di Torino

Berger A; Aron M; Fiscus G; Joshi S; Smith J; Mottrie A; Vidit S; Gandaglia G; Morlacco A; Albisinni S; van Velthoven R; Roupret M; Taille A; Piechaud T; Smelzo S; Joniau S; Palou J; Persad R; Gillatt D; Cahill D; Popert R; Challacombe B; Dasgupta P; Goonewardene S; Sanchez-Salas R; Linares E; Ricardi U; Filippini C; Munoz F; et alii...

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5.

2021
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Novak U; Osborne W; Frezzato M; Fox CP; Davies A; Cascavilla N; Bernardi M; Gastaldi E; Cozens K; Bromberg JEC; Singh V; Fanni A; Re F; Patti C; McKay P; Olivieri J; Linton K; Nassi L; Cellini C; Botto B; Cattaneo C; Khwaja J; Luppi M; Calimeri T; Doorduijn JK; Re A; Cabras MG; Smith J; et alii...

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

2017
AOU Città della Salute di Torino

Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; La Rosée P; Binder M; Fabbri A; Torri V; Minacapelli E; Falautano M; Ilariucci F; Ambrosetti A; Roth A; Hemmaway C; Johnson P; Linton KM; Pukrop T; Sønderskov Gørløv J; Balzarotti M; Hess G; Keller U; Stilgenbauer S; Panse J; Tucci A; Orsucci L; Pisani F; Levis A; Krause SW; et alii...

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. in Science translational medicine / Sci Transl Med. 2016 Jun 1;8(341):341ra76. doi: 10.1126/scitranslmed.aad3744.

2016
AOU Città della Salute di Torino

Scott RA; Freitag DF; Li L; Chu AY; Surendran P; Young R; Grarup N; Stancáková A; Chen Y; Varga TV; Yaghootkar H; Luan J; Zhao JH; Willems SM; Wessel J; Wang S; Maruthur N; Michailidou K; Pirie A; van der Lee SJ; Gillson C; Al Olama AA; Amouyel P; Arriola L; Arveiler D; Aviles-Olmos I; Balkau B; Barricarte A; Barroso I; et alii...